D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 40 Citations 8,232 73 World Ranking 3500 National Ranking 32

Research.com Recognitions

Awards & Achievements

2002 - Prince Mahidol Award

1970 - Robert Koch Prize

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Gene
  • Enzyme

P. Helena Mäkelä mostly deals with Immunology, Microbiology, Vaccination, Streptococcus pneumoniae and Meningococcal vaccine. His research in Immunology tackles topics such as Internal medicine which are related to areas like Surgery and Primary care. His biological study spans a wide range of topics, including Bacteria, Virology, Antigen and Escherichia coli.

His Vaccination research is multidisciplinary, incorporating perspectives in Polysaccharide Vaccine and Haemophilus influenzae type. His Pneumococcal infections study in the realm of Streptococcus pneumoniae interacts with subjects such as Carriage. His Meningococcal vaccine study incorporates themes from Incidence and Meningococcal disease.

His most cited work include:

  • ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS: Implications for Vaccine Development and Pathogenesis (690 citations)
  • The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b (488 citations)
  • Haemophilus influenzae Type b Capsular Polysaccharide Vaccine in Children: A Double-Blind Field Study of 100,000 Vaccinees 3 Months to 5 Years of Age in Finland (399 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Immunology, Salmonella, Vaccination and Antibody. The various areas that he examines in his Microbiology study include Virology, Antigen, Escherichia coli, Bacteria and Virulence. His Immunology study combines topics from a wide range of disciplines, such as Haemophilus influenzae, Group A and Streptococcus pneumoniae.

His Vaccination research is multidisciplinary, incorporating elements of Adverse effect, Meningococcal vaccine, Polysaccharide Vaccine, Pediatrics and Conjugate vaccine. In Meningococcal vaccine, P. Helena Mäkelä works on issues like Prevalence, which are connected to Meningitis. His study looks at the intersection of Polysaccharide Vaccine and topics like Polysaccharide with Haemophilus influenzae type.

He most often published in these fields:

  • Microbiology (48.54%)
  • Immunology (33.98%)
  • Salmonella (22.33%)

What were the highlights of his more recent work (between 2001-2013)?

  • Streptococcus pneumoniae (15.53%)
  • Microbiology (48.54%)
  • Serotype (13.59%)

In recent papers he was focusing on the following fields of study:

His main research concerns Streptococcus pneumoniae, Microbiology, Serotype, Immunology and Otitis. His work on Pneumococcal infections as part of general Streptococcus pneumoniae research is frequently linked to Carriage and Good laboratory practice, bridging the gap between disciplines. His Microbiology research incorporates themes from Bacterial outer membrane, Antibody and Medical physics.

P. Helena Mäkelä has researched Bacterial outer membrane in several fields, including Chlamydophila pneumoniae, Viral vector, Antigen and Virology. His Serotype research also works with subjects such as

  • Regulator gene that intertwine with fields like Invasive disease and Antibiotic resistance genes,
  • Genome which connect with Phylogenetics,
  • Virulence which connect with Chromosome, O-Antigens, Bacteria and Salmonella. He has included themes like Pneumococcal conjugate vaccine and Haemophilus influenzae in his Immunology study.

Between 2001 and 2013, his most popular works were:

  • Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. (217 citations)
  • Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. (136 citations)
  • Association of Clinical Signs and Symptoms with Bacterial Findings in Acute Otitis Media (98 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Gene
  • Enzyme

The scientist’s investigation covers issues in Streptococcus pneumoniae, Microbiology, Pneumococcal infections, Immunology and Otitis. The concepts of his Microbiology study are interwoven with issues in Odds ratio, Bacterial outer membrane and Bacillus subtilis. His Odds ratio study combines topics in areas such as Disease, Multilocus sequence typing, Genotype and Streptococcaceae.

His study in Pneumococcal infections is interdisciplinary in nature, drawing from both Pneumococcal conjugate vaccine, Meningococcal vaccine and Meningococcal disease. His studies deal with areas such as Moraxella catarrhalis, Internal medicine and Myringotomy as well as Immunology. The various areas that P. Helena Mäkelä examines in his Otitis study include Haemophilus influenzae and Moraxella catarrhalis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS: Implications for Vaccine Development and Pathogenesis

Jukka Finne;Maija Leinonen;P.Helena Mäkelä.
The Lancet (1983)

942 Citations

The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b

Relena Käyhty;Heikki Peltola;Viena Karanko;P. Helena Mäkelä.
The Journal of Infectious Diseases (1983)

754 Citations

Haemophilus influenzae Type b Capsular Polysaccharide Vaccine in Children: A Double-Blind Field Study of 100,000 Vaccinees 3 Months to 5 Years of Age in Finland

Heikki Peltola;Helena Käythy;Aulikki Sivonen;P. Helena Mäkelä.
Pediatrics (1977)

609 Citations

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

Heikki Peltola;P. Helena Mäkelä;Helena Käyhty;Hannele Jousimies.
The New England Journal of Medicine (1977)

423 Citations

Lipopolysaccharide Heterogeneity in Salmonella typhimurium Analyzed by Sodium Dodecyl Sulfate/Polyacrylamide Gel Electrophoresis

E. Tapio Palva;P. Helena Mäkelä.
FEBS Journal (1980)

393 Citations

MANNOSE-RESISTANT HAEMAGGLUTINATION AND P ANTIGEN RECOGNITION ARE CHARACTERISTIC OF ESCHERICHIA COLI CAUSING PRIMARY PYELONEPHRITIS

Vuokko Väisänen;Vuokko Väisänen;LeifG. Tallgren;LeifG. Tallgren;P. Helena Mäkelä;P. Helena Mäkelä;Gunilla Källenius;Gunilla Källenius.
The Lancet (1981)

378 Citations

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen.
Clinical Infectious Diseases (2003)

330 Citations

Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland

P. Helena Mäkelä;Heikki Peltola;Helena Käyhty;Hannele Jousimies.
The Journal of Infectious Diseases (1977)

279 Citations

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.

Camilla Jokinen;Leena Heiskanen;Helvi Juvonen;Sakari Kallinen.
Clinical Infectious Diseases (2001)

225 Citations

Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.

Helena Käyhty;Viena Karanko;Heikki Peltola;P. Helena Mäkelä.
Pediatrics (1984)

211 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing P. Helena Mäkelä

Dan M. Granoff

Dan M. Granoff

UCSF Benioff Children's Hospital

Publications: 74

Helena Käyhty

Helena Käyhty

National Institutes of Health

Publications: 61

Andrew J. Pollard

Andrew J. Pollard

University of Oxford

Publications: 59

Ray Borrow

Ray Borrow

Manchester Royal Infirmary

Publications: 55

Timo K. Korhonen

Timo K. Korhonen

University of Helsinki

Publications: 51

Ron Dagan

Ron Dagan

Ben-Gurion University of the Negev

Publications: 44

Jan Poolman

Jan Poolman

Janssen (Belgium)

Publications: 41

Martin C. J. Maiden

Martin C. J. Maiden

University of Oxford

Publications: 36

Keith P. Klugman

Keith P. Klugman

Bill & Melinda Gates Foundation

Publications: 35

Heikki Peltola

Heikki Peltola

University of Helsinki

Publications: 34

Rino Rappuoli

Rino Rappuoli

Imperial College London

Publications: 32

Kathrin U. Jansen

Kathrin U. Jansen

Pfizer (United States)

Publications: 30

Rachel Schneerson

Rachel Schneerson

National Institutes of Health

Publications: 29

Dominique A. Caugant

Dominique A. Caugant

Norwegian Institute of Public Health

Publications: 28

David Goldblatt

David Goldblatt

University College London

Publications: 28

Paul T. Heath

Paul T. Heath

St George's, University of London

Publications: 24

Trending Scientists

Piotr Berman

Piotr Berman

Pennsylvania State University

Michel Galley

Michel Galley

Microsoft (United States)

Yongguang Zhang

Yongguang Zhang

Microsoft Research Asia (China)

Tayfun Akin

Tayfun Akin

Middle East Technical University

Xiaoping Shen

Xiaoping Shen

Jiangsu University

Jianzhang Zhao

Jianzhang Zhao

Dalian University of Technology

B.L. Xiao

B.L. Xiao

Chinese Academy of Sciences

Osamu Takai

Osamu Takai

Kanto Gakuin University

Astrid Oberson

Astrid Oberson

ETH Zurich

Jill Baumgartner

Jill Baumgartner

McGill University

Hardy Temmink

Hardy Temmink

Wageningen University & Research

Marita Troye-Blomberg

Marita Troye-Blomberg

Stockholm University

Frederick T. L. Leong

Frederick T. L. Leong

Michigan State University

Berthold Koletzko

Berthold Koletzko

Ludwig-Maximilians-Universität München

Stefan Bouzarovski

Stefan Bouzarovski

University of Manchester

Something went wrong. Please try again later.